Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corporation
Your view on APTCF
Overview
What the company does, where it operates, and who runs it.
About Advanced Proteome Therapeutics Corporation
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Benjamin Krantz
- Headquarters
- 8337 Eastlake Drive, Burnaby, BC, CA
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Benjamin Krantz
- Headquarters
- 8337 Eastlake Drive, Burnaby, BC, CA
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.